Abstract
Various ethical concerns that are essential elements in the critical trial of any new treatment modality are examined. Problems surrounding the issue of informed consent are considered. Conflicts between therapeutic and research considerations are discussed. The role of double-blind studies is examined.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: IEEE engineering in medicine and biology magazine : the quarterly magazine of the Engineering in Medicine & Biology Society
Paper Title
Journal
Date
